DXCM
DexCom Inc
87.50$
-0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.6% | 12.9% | 22.7% | 27.8% | 20.1% | 27.1% | 17.7% | 26.2% | 54.6% | 23.3% | 44.1% | 20.6% | 35.2% | |
| 4.9% | 5.1% | 5.7% | 5.2% | 5.6% | 5.2% | 5.8% | 5.4% | 5.3% | 5.2% | 5.6% | 5.2% | 5.3% | |
| 4.0% | 3.6% | 4.2% | 4.5% | 4.4% | 3.9% | 3.3% | 3.9% | 3.7% | 2.8% | 3.6% | 3.0% | 3.3% | |
| -6.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 16.7% | -24.9% | 2.1% | 6.7% | 1.6% | 0.6% | 0.0% | 1.9% | 19.2% | -12.0% | 18.0% | -7.5% | 4.0% | |
| 5.2% | 5.1% | 6.2% | 6.6% | 11.2% | 11.2% | 8.4% | 8.1% | 6.7% | 8.1% | 6.4% | 6.5% | 6.9% | |
| -18.4% | 40.1% | 8.1% | -18.8% | 21.2% | -27.3% | 9.7% | -5.5% | 15.9% | 24.3% | -25.0% | 25.2% | 10.7% | |
| 0.0% | -48.3% | – | – | -75.4% | 0.0% | – | – | -15.5% | -24.8% | -3.0% | -46.1% | -22.9% | |
| -66.7% | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| -65.4% | -61.1% | 0.5% | -0.1% | -74.1% | -0.1% | 1.2% | -0.1% | -14.5% | -120.8% | -2.1% | -46.4% | -46.9% | |
| -56.5% | -7.5% | 30.9% | 8.8% | -31.9% | -1.4% | 28.8% | 22.0% | 55.9% | -72.9% | 16.7% | -1.0% | -1.1% | |
| 22.4% | 7.8% | 16.5% | 21.2% | 8.9% | 15.9% | 9.3% | 18.1% | 47.9% | 15.3% | 37.7% | 14.1% | 28.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.